|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2004-4-15
|
|
pubmed:abstractText |
To determine the effectiveness of an infusional chemotherapy regimen in patients with HIV-associated lymphoma treated before and after the use of highly active antiretroviral therapy (HAART) in routine clinical practice.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1491-500
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:15084622-Adult,
pubmed-meshheading:15084622-Aged,
pubmed-meshheading:15084622-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15084622-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15084622-Cyclophosphamide,
pubmed-meshheading:15084622-Doxorubicin,
pubmed-meshheading:15084622-Etoposide,
pubmed-meshheading:15084622-Humans,
pubmed-meshheading:15084622-Lymphoma, AIDS-Related,
pubmed-meshheading:15084622-Middle Aged,
pubmed-meshheading:15084622-Prognosis,
pubmed-meshheading:15084622-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494).
|
|
pubmed:affiliation |
Albert Einstein Cancer Center and Montefiore Medical Center, Weiler Division, 1825 Eastchester Road/2 South, Rm 47-48, Bronx, NY 10461, USA. jsparano@montefiore.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Clinical Trial, Phase II
|
